AURORA, Colo.--(BUSINESS WIRE)--Vitro Diagnostics, Inc. (OTCBB:VODG), dba Vitro Biopharma, announced that Dr. Tinalyn Kupfer, formerly Technical Director of the Rocky Mountain Islet Transplant Program has joined Vitro’s scientific team that is developing stem cell-derived human pancreatic beta islets for commercial applications in research and drug development. Dr. Kupfer’s expertise will be applied to preclinical transplant studies of the Company’s stem cell-derived islets to determine if these islets reverse diabetes. This is an important evaluation for establishing the potential capacity to treat diabetes in animals and humans.
